During the past decade, Maricopa Integrated Health System conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maricopa Integrated Health System" #1 sponsor was "Valleywise Health" with 8 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Emory University" with 2 trials sponsored, "Sera Prognostics, Inc." with 2 trials sponsored and "Agendia" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maricopa Integrated Health System" #1 collaborator was "Agency for Healthcare Research and Quality (AHRQ)" with 2 trials as a collaborator, "Arizona State University" with 1 trials as a collaborator, "Bio-Medical Research, Ltd." with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Fertility Centers of Arizona" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Maricopa Integrated Health System" are "Traumatic Brain Injury" (3 trials), "Influenza" (2 trials), "Preterm Birth" (2 trials), "Ulcerative Colitis" (2 trials) and "Abscess" (1 trials). Many other conditions were trialed in "Maricopa Integrated Health System" in a lesser frequency.

Most popular intervention types in "Maricopa Integrated Health System" are "Drug" (10 trials), "Device" (4 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Crotalidae Polyvalent Immune Fab, ovine" (1 trials), "Crotalinae (pit viper) equine immune F(ab)2" (1 trials), "EFV/FTC/TDF" (1 trials) and "EFV/FTC/TDF Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maricopa Integrated Health System" are 17 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Maricopa Integrated Health System". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Maricopa Integrated Health System, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Maricopa Integrated Health System, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".